Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
1.
Asian Pac J Cancer Prev ; 20(5): 1377-1387, 2019 May 25.
Article in English | MEDLINE | ID: mdl-31127896

ABSTRACT

Objective: Three vaccines are available to Taiwanese young girls for cervical cancer (CC) prevention. Here we evaluate the cost-effectiveness of the two-dose (2D) AS04-adjuvanted HPV-16/18 vaccine (2D-AS04-HPV- 16/18v)+screening compared with a screening programme alone, with 2D human papillomavirus 6/11/16/18 vaccine (2D-4vHPVv)+screening, and with 2D/three-dose (3D) human papillomavirus 6/11/16/18/31/33/45/52/58 vaccine (9vHPVv)+screening, for Taiwan universal mass vaccination. Methods: A static Markov cohort model simulated the natural history of human papillomavirus (HPV) infection and CC screening for a 12-year-old cohort of Taiwanese girls (N=120,000). The model ran in 1-year cycles over the cohort's lifetime. Vaccine efficacy irrespective of HPV type was considered in the analysis for each vaccine. Input data were obtained from published literature, local databases, government reports and websites, and expert opinion. The analysis incorporated direct medical costs only, with an annual discount rate of 3.0%. The threshold was determined as 1 Gross Domestic Product per capita (New Taiwan dollar [NT$] 727,818; year 2016). Results: The 2D-AS04-HPV-16/18v+screening yielded 0.0365 quality-adjusted life year (QALY) gained at an additional cost of NT$ 5,770 per person compared with the screening programme alone. This resulted in an incremental cost-effectiveness ratio well below the threshold. Compared with 2D-4vHPVv+screening and 2D/3D-9vHPVv+screening, discounted results demonstrated additional QALYs gained at lower cost for 2D-AS04-HPV- 16/18v+screening, making it dominant over both 2D-4vHPVv+screening and 2D/3D-9vHPVv+screening. Conclusions: Vaccinating Taiwanese girls with 2D-AS04-HPV-16/18v in addition to screening to prevent CC is cost-effective compared with using a screening programme alone and the dominant option compared with 2D-4vHPVv+screening and 2D/3D-9vHPVv+screening.


Subject(s)
Cost-Benefit Analysis , Early Detection of Cancer/economics , Papillomaviridae/isolation & purification , Papillomavirus Infections/economics , Papillomavirus Vaccines/economics , Uterine Cervical Neoplasms/economics , Vaccination/economics , Adolescent , Adult , Aged , Aged, 80 and over , Child , Cohort Studies , Female , Follow-Up Studies , Humans , Incidence , Markov Chains , Middle Aged , Papillomaviridae/classification , Papillomavirus Infections/prevention & control , Papillomavirus Infections/virology , Papillomavirus Vaccines/administration & dosage , Prognosis , Quality-Adjusted Life Years , Survival Rate , Taiwan/epidemiology , Uterine Cervical Neoplasms/epidemiology , Uterine Cervical Neoplasms/prevention & control , Uterine Cervical Neoplasms/virology , Young Adult
2.
Sci Rep ; 7(1): 1943, 2017 05 16.
Article in English | MEDLINE | ID: mdl-28512358

ABSTRACT

Induced pluripotent stem cell-derived neural progenitor cells (iPSC-NPCs) are a promising source of tailor-made cell therapy for neurological diseases. However, major obstacles to clinical use still exist. To circumvent complications related to intracerebral administration, we implanted human iPSC-NPCs epidurally over the peri-infarct cortex 7 days after permanent middle cerebral artery occlusion in adult rats. Compared to controls, cell-treated rats showed significant improvements in paretic forelimb usage and grip strength from 10 days post-transplantation (dpt) onwards, as well as reductions in lesion volumes, inflammatory infiltration and astrogliosis at 21 dpt. Few iPSC-NPCs migrated into rat peri-infarct cortices and exhibited poor survival in tissue. To examine the paracrine therapeutic mechanisms of epidural iPSC-NPC grafts, we used transmembrane co-cultures of human iPSC-NPCs with rat cortical cells subjected to oxygen-glucose deprivation. Compared to other human stem cells, iPSC-NPCs were superior at promoting neuronal survival and outgrowth, and mitigating astrogliosis. Using comparative whole-genome microarrays and cytokine neutralization, we identified a neurorestorative secretome from iPSC-NPCs, and neutralizing enriched cytokines abolished neuroprotective effects in co-cultures. This proof-of-concept study demonstrates a relatively safe, yet effective epidural route for delivering human iPSC-NPCs, which acts predominately through discrete paracrine effects to promote functional recovery after stroke.


Subject(s)
Cell Differentiation , Induced Pluripotent Stem Cells/cytology , Neural Stem Cells/cytology , Stem Cell Transplantation , Stroke Rehabilitation , Stroke/therapy , Animals , Cells, Cultured , Cerebral Cortex/cytology , Cerebral Cortex/metabolism , Gene Expression , Gene Regulatory Networks , Humans , Male , Paracrine Communication , Rats , Stem Cell Transplantation/methods , Stroke/pathology , Young Adult
3.
OMICS ; 20(3): 191-8, 2016 Mar.
Article in English | MEDLINE | ID: mdl-26910904

ABSTRACT

Organ regeneration therapies using multipotent mesenchymal stem cells (MSCs) are currently being investigated for a variety of common complex diseases. Understanding the molecular regulation of MSC biology will benefit regenerative medicine. MicroRNAs (miRNAs) act as regulators in MSC stemness. There are approximately 2500 currently known human miRNAs that have been recorded in the miRBase v21 database. In the present study, we identified novel microRNAs involved in MSC stemness and differentiation by obtaining the global microRNA expression profiles (miRNomes) of MSCs from two anatomical locations bone marrow (BM-MSCs) and umbilical cord Wharton's jelly (WJ-MSCs) and from osteogenically and adipogenically differentiated progenies of BM-MSCs. Small RNA sequencing (smRNA-seq) and bioinformatics analyses predicted that 49 uncharacterized miRNA candidates had high cellular expression values in MSCs. Another independent batch of Ago1/2-based RNA immunoprecipitation (RNA-IP) sequencing datasets validated the existence of 40 unreported miRNAs in cells and their associations with the RNA-induced silencing complex (RISC). Nine of these 40 new miRNAs were universally overexpressed in both MSC types; nine others were overexpressed in differentiated cells. A novel miRNA (UNI-118-3p) was specifically expressed in BM-MSCs, as verified using RT-qPCR. Taken together, this report offers comprehensive miRNome profiles for two MSC types, as well as cells differentiated from BM-MSCs. MSC transplantation has the potential to ameliorate degenerative disorders and repair damaged tissues. Interventions involving the above 40 new microRNA members in transplanted MSCs may potentially guide future clinical applications.


Subject(s)
Bone Marrow Cells/metabolism , Mesenchymal Stem Cells/metabolism , MicroRNAs/genetics , RNA-Induced Silencing Complex/genetics , Adipocytes/cytology , Adipocytes/metabolism , Bone Marrow Cells/cytology , Cell Differentiation , Cell Proliferation , Gene Expression Regulation , Humans , Immunoprecipitation , Mesenchymal Stem Cells/cytology , MicroRNAs/metabolism , Osteoblasts/cytology , Osteoblasts/metabolism , RNA-Induced Silencing Complex/metabolism , Sequence Analysis, RNA , Umbilical Cord/cytology , Umbilical Cord/metabolism
4.
J Hepatol ; 61(6): 1276-86, 2014 Dec.
Article in English | MEDLINE | ID: mdl-25073010

ABSTRACT

BACKGROUND & AIMS: Hepatocyte-like cells, differentiated from different stem cell sources, are considered to have a range of possible therapeutic applications, including drug discovery, metabolic disease modelling, and cell transplantation. However, little is known about how stem cells differentiate into mature and functional hepatocytes. METHODS: Using transcriptomic screening, a transcription factor, liver X receptor α (NR1H3), was identified as increased during HepaRG cell hepatogenesis; this protein was also upregulated during embryonic stem cell and induced pluripotent stem cell differentiation. RESULTS: Overexpressing NR1H3 in human HepaRG cells promoted hepatic maturation; the hepatocyte-like cells exhibited various functions associated with mature hepatocytes, including cytochrome P450 (CYP) enzyme activity, secretion of urea and albumin, upregulation of hepatic-specific transcripts and an increase in glycogen storage. Importantly, the NR1H3-derived hepatocyte-like cells were able to rescue lethal fulminant hepatic failure using a non-obese diabetic/severe combined immunodeficient mouse model. CONCLUSIONS: In this study, we found that NR1H3 accelerates hepatic differentiation through an HNF4α-dependent reciprocal network. This contributes to hepatogenesis and is therapeutically beneficial to liver disease.


Subject(s)
Cell Differentiation/physiology , Hepatocyte Nuclear Factor 4/physiology , Hepatocytes/physiology , Orphan Nuclear Receptors/physiology , Stem Cells/physiology , Animals , Carbon Tetrachloride/adverse effects , Cell Line , Cell Transplantation , Disease Models, Animal , Hepatocytes/cytology , Humans , In Vitro Techniques , Liver Failure/chemically induced , Liver Failure/therapy , Liver Regeneration/physiology , Liver X Receptors , Mice , Mice, Inbred NOD , Mice, SCID , Stem Cells/cytology
5.
Carcinogenesis ; 35(10): 2164-74, 2014 Oct.
Article in English | MEDLINE | ID: mdl-24832085

ABSTRACT

Embryonal tumors of the central nervous system represent a highly malignant tumor group of medulloblastoma (MB), atypical teratoid/rhabdoid tumor (AT/RT) and primitive neuroectodermal tumor that frequently afflict children. AT/RT is often misdiagnosed as MB/primitive neuroectodermal tumor but with higher recurrence and lower survival rates. Pathogenesis of AT/RT is largely unknown. In this study, we report both the miRNome and transcriptome traits in AT/RT and MB by using small RNA sequencing and gene expression microarray analyses. Our findings demonstrate that the miR-221/222-encoded micro RNAs are abundantly expressed in AT/RT but not in MB, which contribute substantially to the malignancy of embryonal tumors. miR-221/222 targeted SUN2, a newly discovered tumor suppressor, directly to increase cell proliferation and tumor malignancy in vitro and in vivo. Immunohistochemistry against SUN2 in a tissue microarray of 33 AT/RT and 154 MB tumor specimens also detected less SUN2 protein in AT/RT. Collectively, this study uncovers a novel tumor suppressor, SUN2, plays a critical role in miR-221/222-mediated AT/RT malignancy as well as supports miR-221/222 and SUN2 represent new promising targets for more active therapies in AT/RT. In addition, our miRNome and transcriptome data also provide a roadmap for further embryonal tumor research.


Subject(s)
Intracellular Signaling Peptides and Proteins/genetics , Membrane Proteins/genetics , MicroRNAs/genetics , Neoplasms, Germ Cell and Embryonal/genetics , Animals , Brain Neoplasms/genetics , Brain Neoplasms/mortality , Cerebellar Neoplasms/genetics , Cerebellar Neoplasms/mortality , Child , Child, Preschool , Down-Regulation , Female , Gene Expression Regulation, Neoplastic , Genes, Tumor Suppressor , Humans , Intracellular Signaling Peptides and Proteins/metabolism , Male , Medulloblastoma/genetics , Medulloblastoma/mortality , Membrane Proteins/metabolism , Mice, Inbred NOD , Neoplasms, Germ Cell and Embryonal/mortality , Neuroectodermal Tumors, Primitive/genetics , Neuroectodermal Tumors, Primitive/mortality , Rhabdoid Tumor/genetics , Rhabdoid Tumor/mortality , Xenograft Model Antitumor Assays
6.
Nucleic Acids Res ; 41(21): 9753-63, 2013 Nov.
Article in English | MEDLINE | ID: mdl-23963696

ABSTRACT

Administration of mesenchymal stem cells (MSCs) has the potential to ameliorate degenerative disorders and to repair damaged tissues. The homing of transplanted MSCs to injured sites is a critical property of engraftment. Our aim was to identify microRNAs involved in controlling MSC proliferation and migration. MSCs can be isolated from bone marrow and umbilical cord Wharton's jelly (BM-MSCs and WJ-MSCs, respectively), and WJ-MSCs show poorer motility yet have a better amplification rate compared with BM-MSCs. Small RNA sequencing revealed that miR-146a-5p is significantly overexpressed and has high abundance in WJ-MSCs. Knockdown of miR-146a-5p in WJ-MSCs inhibited their proliferation yet enhanced their migration, whereas overexpression of miR-146a-5p in BM-MSCs did not influence their osteogenic and adipogenic potentials. Chemokine (C-X-C motif) ligand 12 (CXCL12), together with SIKE1, which is an I-kappa-B kinase epsilon (IKKε) suppressor, is a direct target of miR-146a-5p in MSCs. Knockdown of miR-146a-5p resulted in the down-regulation of nuclear factor kappa-B (NF-κB) activity, which is highly activated in WJ-MSCs and is known to activate miR-146a-5p promoter. miR-146a-5p is also downstream of CXCL12, and a negative feedback loop is therefore formed in MSCs. These findings suggest that miR-146a-5p is critical to the uncoupling of motility and proliferation of MSCs. Our miRNome data also provide a roadmap for further understanding MSC biology.


Subject(s)
Cell Movement , Cell Proliferation , Mesenchymal Stem Cells/cytology , Mesenchymal Stem Cells/metabolism , MicroRNAs/physiology , Cell Differentiation , Cells, Cultured , Chemokine CXCL12/genetics , Chemokine CXCL12/metabolism , Humans , Intracellular Signaling Peptides and Proteins/genetics , Intracellular Signaling Peptides and Proteins/metabolism , MicroRNAs/metabolism
7.
PLoS One ; 8(8): e72604, 2013.
Article in English | MEDLINE | ID: mdl-23991127

ABSTRACT

Mesenchymal stem cells (MSCs) are promising tools for the treatment of diseases such as infarcted myocardia and strokes because of their ability to promote endogenous angiogenesis and neurogenesis via a variety of secreted factors. MSCs found in the Wharton's jelly of the human umbilical cord are easily obtained and are capable of transplantation without rejection. We isolated MSCs from Wharton's jelly and bone marrow (WJ-MSCs and BM-MSCs, respectively) and compared their secretomes. It was found that WJ-MSCs expressed more genes, especially secreted factors, involved in angiogenesis and neurogenesis. Functional validation showed that WJ-MSCs induced better neural differentiation and neural cell migration via a paracrine mechanism. Moreover, WJ-MSCs afforded better neuroprotection efficacy because they preferentially enhanced neuronal growth and reduced cell apoptotic death of primary cortical cells in an oxygen-glucose deprivation (OGD) culture model that mimics the acute ischemic stroke situation in humans. In terms of angiogenesis, WJ-MSCs induced better microvasculature formation and cell migration on co-cultured endothelial cells. Our results suggest that WJ-MSC, because of a unique secretome, is a better MSC source to promote in vivo neurorestoration and endothelium repair. This study provides a basis for the development of cell-based therapy and carrying out of follow-up mechanistic studies related to MSC biology.


Subject(s)
Mesenchymal Stem Cells/metabolism , Neovascularization, Physiologic , Neurogenesis , Umbilical Cord/cytology , Cells, Cultured , Coculture Techniques , Culture Media, Conditioned , Humans , Mesenchymal Stem Cells/cytology , Real-Time Polymerase Chain Reaction
8.
Bioorg Med Chem ; 21(7): 2163-76, 2013 Apr 01.
Article in English | MEDLINE | ID: mdl-23465436

ABSTRACT

Helioxanthin and analogues have been demonstrated to suppress gene expression of human hepatitis B virus. In the continuous attempt to optimize antiviral activity, various structural motifs were grafted on the helioxanthin scaffold. Many such analogues were synthesized and evaluated for their anti-hepatitis B virus activity. Structure-activity relationships of these helioxanthin derivatives are also discussed. Among these new compounds, 15 exhibits the highest activity against HBV (EC50=0.06 µM). This compound can suppress viral surface antigen and DNA expression. Furthermore, viral RNA is also diminished while the core promoter is deactivated upon treatment by 15. A plausible working mechanism is postulated. Our results establish helioxanthin lignans as potent anti-HBV agents with unique mode of action. Since their antiviral mechanism is distinct from current nucleoside/nucleotide drugs, helioxanthin lignans constitute a potentially new class of anti-HBV agents for combination therapy.


Subject(s)
Antiviral Agents/chemistry , Antiviral Agents/pharmacology , Gene Expression Regulation, Viral/drug effects , Hepatitis B virus/drug effects , Hepatitis B/drug therapy , Lignans/chemistry , Lignans/pharmacology , Antiviral Agents/chemical synthesis , DNA, Viral/genetics , Hep G2 Cells , Hepatitis B/virology , Hepatitis B virus/genetics , Humans , Lignans/chemical synthesis , RNA, Viral/genetics , Structure-Activity Relationship
9.
BMC Med Genomics ; 4: 65, 2011 Sep 19.
Article in English | MEDLINE | ID: mdl-21923954

ABSTRACT

BACKGROUND: Mesenchymal stem cell (MSC) found in bone marrow (BM-MSCs) and the Wharton's jelly matrix of human umbilical cord (WJ-MSCs) are able to transdifferentiate into neuronal lineage cells both in vitro and in vivo and therefore hold the potential to treat neural disorders such as stroke or Parkinson's disease. In bone marrow MSCs, miR-130a and miR-206 have been show to regulate the synthesis of neurotransmitter substance P in human mesenchymal stem cell-derived neuronal cells. However, how neuronal differentiation is controlled in WJ-MSC remains unclear. METHODS: WJ-MSCs were isolated from human umbilical cords. We subjected WJ-MSCs into neurogenesis by a published protocol, and the miRNome patterns of WJ-MSCs and their neuronal progenitors (day 9 after differentiation) were analyzed by the Agilent microRNA microarray. RESULTS: Five miRNAs were enriched in WJ-MSCs, including miR-345, miR-106a, miR-17-5p, miR-20a and miR-20b. Another 11 miRNAs (miR-206, miR-34a, miR-374, miR-424, miR-100, miR-101, miR-323, miR-368, miR-137, miR-138 and miR-377) were abundantly expressed in transdifferentiated neuronal progenitors. Among these miRNAs, miR-34a and miR-206 were the only 2 miRNAs been linked to BM-MSC neurogenesis. Overexpressing miR-34a in cells suppressed the expression of 136 neuronal progenitor genes, which all possess putative miR-34a binding sites. Gene enrichment analysis according to the Gene Ontology database showed that those 136 genes were associated with cell motility, energy production (including those with oxidative phosphorylation, electron transport and ATP synthesis) and actin cytoskeleton organization, indicating that miR-34a plays a critical role in precursor cell migration. Knocking down endogenous miR-34a expression in WJ-MSCs resulted in the augment of WJ-MSC motility. CONCLUSIONS: Our data suggest a critical role of miRNAs in MSC neuronal differentiation, and miR-34a contributes in neuronal precursor motility, which may be crucial for stem cells to home to the target sites they should be.


Subject(s)
Mesenchymal Stem Cells/cytology , MicroRNAs/metabolism , Neurons/cytology , Actin Cytoskeleton/genetics , Binding Sites , Cell Movement/genetics , Cell Transdifferentiation , Energy Metabolism/genetics , Fetal Blood/cytology , Humans , Mesenchymal Stem Cells/metabolism , MicroRNAs/genetics , Microarray Analysis , Neurogenesis , Neurons/metabolism , Oxidative Phosphorylation
10.
Stem Cells Dev ; 19(12): 1895-910, 2010 Dec.
Article in English | MEDLINE | ID: mdl-20367285

ABSTRACT

Mesenchymal stem cells (MSCs) found in bone marrow (BM)-MSCs are an attractive source for the regeneration of damaged tissues. Alternative postnatal, perinatal, and fetal sources of MSCs are also under intensive investigation. MSCs from the Wharton's jelly matrix of umbilical cord (WJ)-MSCs have higher pancreatic and endothelial differentiation potentials than BM-MSCs, but the underlying mechanisms are poorly understood. We compared the gene expression profiles, enriched canonical pathways, and genetic networks of BM-MSCs and WJ-MSCs. WJ-MSCs express more angiogenesis- and growth-related genes including epidermal growth factor and FLT1, whereas BM-MSCs express more osteogenic genes such as RUNX2, DLX5, and NPR3. The gene expression pattern of BM-MSCs is more similar to osteoblasts than WJ-MSCs, suggesting a better osteogenic potential. In contrast, WJ-MSCs are more primitive because they share more common genes with embryonic stem cells. BM-MSCs are more sensitive to environmental stimulations because their molecular signatures altered more significantly in different culture conditions. WJ-MSCs express genes enriched in vascular endothelial growth factor and PI3K-NFκB canonical pathways, whereas BM-MSCs express genes involved in antigen presentation and chemokine/cytokine pathways. Drylab results could be verified by wetlab experiments, in which BM-MSCs were more efficient in osteogenic and adipogenic differentiation, whereas WJ-MSCs proliferated better. WJ-MSCs thus constitute a promising option for angiogenesis, whereas BM-MSCs in bone remodeling. Our results reveal systematically the underlying genes and regulatory networks of 2 MSCs from unique ontological and anatomical origins, as well as the resulted phenotypes, thereby providing a better basis for cell-based therapy and the following mechanistic studies on MSC biology.


Subject(s)
Bone Marrow Cells , Mesenchymal Stem Cells/physiology , Osteogenesis , Umbilical Cord/cytology , Antigen Presentation/genetics , Bone Remodeling/physiology , Cells, Cultured , Chemokines/genetics , Cytokines/genetics , Embryonic Stem Cells/cytology , Flow Cytometry , Fluorescent Antibody Technique , Gene Expression Profiling , Gene Regulatory Networks , Humans , Immunoblotting , Intercellular Signaling Peptides and Proteins/genetics , Mesenchymal Stem Cells/cytology , NF-kappa B/genetics , Neovascularization, Physiologic/genetics , Osteogenesis/genetics , Phosphatidylinositol 3-Kinases/genetics , Polymerase Chain Reaction , Stromal Cells/cytology , Stromal Cells/physiology , Umbilical Cord/physiology , Vascular Endothelial Growth Factor A/genetics
11.
BMC Genomics ; 11: 132, 2010 Feb 24.
Article in English | MEDLINE | ID: mdl-20178649

ABSTRACT

BACKGROUND: Intracranial pediatric germ cell tumors (GCTs) are rare and heterogeneous neoplasms and vary in histological differentiation, prognosis and clinical behavior. Germinoma and mature teratoma are GCTs that have a good prognosis, while other types of GCTs, termed nongerminomatous malignant germ cell tumors (NGMGCTs), are tumors with an intermediate or poor prognosis. The second group of tumors requires more extensive drug and irradiation treatment regimens. The mechanisms underlying the differences in incidence and prognosis of the various GCT subgroups are unclear. RESULTS: We identified a distinct mRNA profile correlating with GCT histological differentiation and prognosis, and also present in this study the first miRNA profile of pediatric primary intracranial GCTs. Most of the differentially expressed miRNAs were downregulated in germinomas, but miR-142-5p and miR-146a were upregulated. Genes responsible for self-renewal (such as POU5F1 (OCT4), NANOG and KLF4) and the immune response were abundant in germinomas, while genes associated with neuron differentiation, Wnt/beta-catenin pathway, invasiveness and epithelial-mesenchymal transition (including SNAI2 (SLUG) and TWIST2) were abundant in NGMGCTs. Clear transcriptome segregation based on patient survival was observed, with malignant NGMGCTs being closest to embryonic stem cells. Chromosome copy number variations (CNVs) at cytobands 4q13.3-4q28.3 and 9p11.2-9q13 correlated with GCT malignancy and clinical risk. Six genes (BANK1, CXCL9, CXCL11, DDIT4L, ELOVL6 and HERC5) within 4q13.3-4q28.3 were more abundant in germinomas. CONCLUSIONS: Our results integrate molecular profiles with clinical observations and provide insights into the underlying mechanisms causing GCT malignancy. The genes, pathways and microRNAs identified have the potential to be novel therapeutic targets.


Subject(s)
Central Nervous System Neoplasms/genetics , DNA Copy Number Variations , MicroRNAs/genetics , Neoplasms, Germ Cell and Embryonal/genetics , Central Nervous System Neoplasms/diagnosis , Child , DNA, Neoplasm/genetics , Gene Expression Profiling , Genomics/methods , Humans , Kruppel-Like Factor 4 , Neoplasms, Germ Cell and Embryonal/diagnosis , Oligonucleotide Array Sequence Analysis , Prognosis , Taiwan
12.
Stem Cells ; 26(5): 1186-201, 2008 May.
Article in English | MEDLINE | ID: mdl-18308945

ABSTRACT

Somatic stem cell transplantation holds great promise in regenerative medicine. The best-characterized adult stem cells are mesenchymal stem cells (MSCs), neural stem cells (NSCs), and CD133(+) hematopoietic stem cells (HSCs). The applications of HSCs are hampered since these cells are difficult to maintain in an undifferentiated state in vitro. Understanding genes responsible for stem cell properties and their interactions will help on this issue. The construction of stem cell genetic networks will also help to develop rational strategies to revert somatic cells back to a stem-like state. We performed a systemic study on human CD133(+) HSCs, NSCs, MSCs, and embryonic stem cells and two different progenies of CD133(+) HSCs, microvascular endothelial cells (MVECs) and peripheral blood mononuclear cells. Genes abundant in each or in all three somatic stem cells were identified. We also observed complex genetic networks functioning in postnatal stem cells, in which several genes, such as PTPN11 and DHFR, acted as hubs to maintain the stability and connectivity of the whole genetic network. Eighty-seven HSC genes, including ANGPT1 and GATA2, were independently identified by comparing CD34(+)CD33(-)CD38(-) hematopoietic stem cells with CD34(+) precursors and various matured progenies. Introducing GATA2 into MVECs resulted in dedifferentiation-like transcriptome reprogramming, with HSC genes (such as ANGPT1) being up and endothelial genes (such as EPHB2) being down. This study provides a foundation for a more detailed understanding of human somatic stem cells. Expressing the newly discovered stem cell genes in matured cells might lead to a global reversion of somatic transcriptome to a stem-like status.


Subject(s)
Cell Dedifferentiation , Cellular Reprogramming , Chromosome Mapping , GATA2 Transcription Factor/metabolism , Gene Expression Profiling , Stem Cells/cytology , Stem Cells/metabolism , AC133 Antigen , Antigens, CD/metabolism , Antigens, CD34/metabolism , Cell Line , Cell Separation , Cluster Analysis , Embryonic Stem Cells/cytology , Embryonic Stem Cells/metabolism , Endothelial Cells/cytology , Endothelial Cells/metabolism , GATA2 Transcription Factor/genetics , Gene Expression Regulation , Gene Regulatory Networks , Glycoproteins/metabolism , Hematopoietic Stem Cells/cytology , Hematopoietic Stem Cells/metabolism , Humans , Mesenchymal Stem Cells/cytology , Mesenchymal Stem Cells/metabolism , Neurons/cytology , Neurons/metabolism , Oligonucleotide Array Sequence Analysis , Peptides/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...